Clinical Trials Browser

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00005951 2014-08-22

Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

Phase 1 Completed

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00352521 2014-07-22

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Phase 2 Completed

20 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00268359 2014-07-21

Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas

Phase 2 Completed

68 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002988 2013-06-20

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Phase 1 Completed

36 enrolled

CNS

Brain Neoplasms, Central Nervous System Neoplasms

NCT00039468 2011-10-27

Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy

Phase 2 Completed

26 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00004068 2011-10-04

Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor

Phase 2 Completed

53 enrolled

CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00010036 2011-03-28

Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme

Phase 2 Completed

CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00251797 2010-01-07

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Phase 1 Completed

10 enrolled

CNS

Brain Neoplasms, Neoplasms, Neurologic Manifestations, Central Nervous System Neoplasms

Clinical Trials

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy

Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor

Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors